(Q34787318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

The endocannabinoid system in obesity and type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

endocannabinoid system

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

V Di Marzo

series ordinal

1

1 reference

4 August 2017

publication date

18 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1356-1367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-008-1048-2

9 January 2020

exact match

0 references

cites work

Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1048-2

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1048-2

Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1048-2

Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1048-2

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

12 December 2020

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin

1 reference

12 December 2020

Effects of cannabinoid receptors on skeletal muscle oxidative pathways

1 reference

12 December 2020

Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results

1 reference

12 December 2020

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

12 December 2020

Recent advantages in cannabinoid research

1 reference

12 December 2020

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

12 December 2020

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

1 reference

12 December 2020

Endocannabinoids and the regulation of their levels in health and disease

1 reference

12 December 2020

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

12 December 2020

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

1 reference

12 December 2020

Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats

1 reference

12 December 2020

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake.

1 reference

12 December 2020

Pharmacological actions of cannabinoids.

1 reference

12 December 2020

Endocannabinoids and the control of energy balance

1 reference

12 December 2020

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

12 December 2020

Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus.

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

12 December 2020

Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases

1 reference

12 December 2020

Presence of functional cannabinoid receptors in human endocrine pancreas

1 reference

12 December 2020

Identification of endocannabinoids and related compounds in human fat cells

1 reference

12 December 2020

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

1 reference

12 December 2020

Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.

1 reference

12 December 2020

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

1 reference

12 December 2020

Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program

1 reference

12 December 2020

Abdominal obesity and metabolic syndrome

1 reference

12 December 2020

CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats

1 reference

12 December 2020

Rimonabant: new data and emerging experience

1 reference

12 December 2020

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

1 reference

12 December 2020

No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents

1 reference

12 December 2020

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats

1 reference

12 December 2020

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

1 reference

12 December 2020

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats

1 reference

12 December 2020

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

1 reference

12 December 2020

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

1 reference

12 December 2020

The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men

1 reference

12 December 2020

Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'.

1 reference

12 December 2020

Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population

1 reference

12 December 2020

The molecular logic of endocannabinoid signalling

1 reference

12 December 2020

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

12 December 2020

Multiple pathways involved in the biosynthesis of anandamide

1 reference

12 December 2020

Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations

1 reference

12 December 2020

Targeting the endocannabinoid system: to enhance or reduce?

1 reference

12 December 2020

Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?

1 reference

12 December 2020

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

1 reference

12 December 2020

The expression of receptors for endocannabinoids in human and rodent skeletal muscle

1 reference

12 December 2020

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

1 reference

12 December 2020

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

12 December 2020

The endocannabinoid system and its therapeutic exploitation

1 reference

12 December 2020

Biochemistry and pharmacology of endovanilloids

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.

1 reference

12 December 2020

Endocannabinoid mechanisms of pain modulation

1 reference

12 December 2020

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

1 reference

12 December 2020

Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice

1 reference

12 December 2020

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

12 December 2020

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

1 reference

12 December 2020

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.

1 reference

12 December 2020

The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids

1 reference

12 December 2020

Role of cannabinoid CB2 receptors in glucose homeostasis in rats

1 reference

12 December 2020

Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain

1 reference

12 December 2020

Activation of the peripheral endocannabinoid system in human obesity

1 reference

12 December 2020

Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors

1 reference

12 December 2020

Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity

1 reference

12 December 2020

Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity

1 reference

12 December 2020

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

12 December 2020

Genetic Variations at the Endocannabinoid Type 1 Receptor Gene (CNR1) Are Associated with Obesity Phenotypes in Men

1 reference

12 December 2020

Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level

1 reference

12 December 2020

The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites

1 reference

12 December 2020

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

1 reference

12 December 2020

The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake

1 reference

12 December 2020

10.1007/S00125-008-1048-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18563385%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 January 2020

1042098570

0 references

1 reference